Please login to the form below

Not currently logged in
Email:
Password:

New operations head for Spirit Healthcare

Quentin Hayes joins from AstraZeneca
Spirit, Quentin Hayes

Spirit Healthcare has appointed an operations director in preparation for continued growth.

Quentin Hayes joins the UK-based healthcare solutions business following a 15 year stint at pharma firm AstraZeneca, where he was an operations manager.

The move marks a change of direction for Hayes with Spirit specialising in the provision healthcare solutions to the NHS and private hospitals. This is focused on diabetes and dermatology.

With two decades' healthcare experience, covering sales, marketing, medical affairs, governance and operations management, Hayes said he was excited to join a company “which is fresh, forward-thinking and bold”.

“I'm going to be working with the company to develop its frameworks for the next exciting period of growth,” he added.

At Spirit, Hayes will be responsible for logistics, customer service, project management, quality management, HR and facilities management. He will report to Spirit managing director Chris Barker and will have 12 people reporting to him, including two managers.

“Quentin will help us take the company to the next level, he's going to be a valuable recruit as we expand,” said Barker.

20th February 2014

From: Healthcare

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Valid Insight

Valid Insight is an award-winning pharmaceutical global market access consultancy....

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics